Cite
Liensinine prevents ischemic injury following myocardial infarction via inhibition of Wnt/β‑catenin signaling activation.
MLA
Shen, Fang, et al. “Liensinine Prevents Ischemic Injury Following Myocardial Infarction via Inhibition of Wnt/Β‑catenin Signaling Activation.” Biomedicine & Pharmacotherapy, vol. 162, June 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.114675.
APA
Shen, F., Wu, C., Zhong, X., Ma, E., Peng, J., Zhu, W., Wo, D., & Ren, D. (2023). Liensinine prevents ischemic injury following myocardial infarction via inhibition of Wnt/β‑catenin signaling activation. Biomedicine & Pharmacotherapy, 162, N.PAG. https://doi.org/10.1016/j.biopha.2023.114675
Chicago
Shen, Fang, Celiang Wu, Xiaomei Zhong, En Ma, Jun Peng, Weidong Zhu, Da Wo, and Dan-ni Ren. 2023. “Liensinine Prevents Ischemic Injury Following Myocardial Infarction via Inhibition of Wnt/Β‑catenin Signaling Activation.” Biomedicine & Pharmacotherapy 162 (June): N.PAG. doi:10.1016/j.biopha.2023.114675.